Skip to content

Copmparsion the effect of olive oil and coconut in preventing mucosities induced by chemotherapy

Comparing the impact of using olive and coconut oils in preventing of chemotherapy induced mucositis in children with leukemia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240126060812N1
Enrollment
100
Registered
2024-02-19
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia. Acute lymphoblastic leukemia [ALL]

Interventions

Intervention 1: Intervention group: In this group, olive oil (Farabakr Company, Rudbar, Iran), which is stored in dark glass containers at room temperature, is used to prevent mucositis. Intervention

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Children 1-14 years old Not receiving any type of treatment in the past Healthy mucosa at the beginning of treatment By obtaining the informed consent of the patient and the patient's parents Children who have not undergone radiotherapy and surgery in addition to chemotherapy.

Exclusion criteria

Exclusion criteria: Children who have undergone chemotherapy, radiotherapy, and surgery Children who, in addition to leukemia, also suffer from other systemic or malignant disorders Children who have received any anti-fungal or anti-viral drug or any substance that is effective on oral mucositis before entering the study.

Design outcomes

Primary

MeasureTime frame
Prevention of mucusitis. Timepoint: In the first days, the first week, and the fourth week after the intervention. Method of measurement: Assessed based on the classification of the World Health Organization and clinical examination of the mucosal status.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mahsa Moradi

Zahedan University of Medical Sciences

dr.mahsamoradi.pediatric@gmail.com+98 54 3345 0105

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026